Cargando…
Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy
BACKGROUND: Endometriosis affects over 10 million women in the United States. Depot leuprolide acetate (LA), a gonadotropin-releasing hormone agonist, has been used extensively for the treatment of women with endometriosis but is associated with hypoestrogenic symptoms and bone mineral density loss....
Autores principales: | Soliman, Ahmed M., Bonafede, Machaon, Farr, Amanda M., Castelli-Haley, Jane, Winkel, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397813/ https://www.ncbi.nlm.nih.gov/pubmed/27123918 http://dx.doi.org/10.18553/jmcp.2016.22.5.573 |
Ejemplares similares
-
Norethindrone Acetate in the Medical Management of Adenomyosis
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012) -
Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children
por: Metbulut, Azize Pınar, et al.
Publicado: (2021) -
Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate
por: DiVasta, Amy D., et al.
Publicado: (2021) -
HT update: spotlight on estradiol/norethindrone acetate combination therapy
por: Casey, Colleen L, et al.
Publicado: (2008) -
Medical management of recurrent endometrioma with long-term norethindrone acetate
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012)